John Foley

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand et al. · Cancer · 1990 · 207 citations · Full text

Medicine, Oncology, Pharmacology +10

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

Patrick Vermersch, Ludwig Kappos, Ralf Gold et al. · Neurology · 2011 · 199 citations

Medicine, Infectious Diseases, Neurology +13

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Lana Zhovtis Ryerson, John Foley, Ih Chang et al. · Neurology · 2019 · 194 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.

S A Belinsky, Theodora R. Devereux, John Foley et al. · PubMed · 1992 · 166 citations

Medicine, Oncology, Pathobiology +15

Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.

George W. Lucier, Angelika Tritscher, Thomas L. Goldsworthy et al. · PubMed · 1991 · 151 citations

Pharmacy, Oncology, Toxicology +17